• Pfizer CFO Dave Denton will step down, leaving the company on Aug. 15 for a consumer goods role outside pharmaceuticals.
• Cecile Guegan, SVP of finance for the global biopharmaceutical business, becomes interim CFO effective Aug. 16.
• Guegan has more than two decades at Pfizer, overseeing biopharma financial operations and reporting across therapeutic areas and geographies.
• Pfizer launched an internal and external search for a permanent CFO.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pfizer Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202606180645BIZWIRE_USPR_____20260618_BW380719) on June 18, 2026, and is solely responsible for the information contained therein.